192.73
price down icon1.33%   -1.49
 
loading
Schlusskurs vom Vortag:
$194.22
Offen:
$194.57
24-Stunden-Volumen:
294.19K
Relative Volume:
0.12
Marktkapitalisierung:
$40.79B
Einnahmen:
$398.11M
Nettoeinkommen (Verlust:
$-1.03B
KGV:
-33.79
EPS:
-5.7032
Netto-Cashflow:
$-868.57M
1W Leistung:
+20.03%
1M Leistung:
+33.07%
6M Leistung:
+166.16%
1J Leistung:
+184.83%
1-Tages-Spanne:
Value
$191.33
$197.08
1-Wochen-Bereich:
Value
$160.53
$197.08
52-Wochen-Spanne:
Value
$60.40
$197.08

Insmed Inc Stock (INSM) Company Profile

Name
Firmenname
Insmed Inc
Name
Telefon
908-977-9900
Name
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
Mitarbeiter
1,271
Name
Twitter
@insmed
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
INSM's Discussions on Twitter

Vergleichen Sie INSM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
INSM
Insmed Inc
192.96 41.29B 398.11M -1.03B -868.57M -5.7032
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.11 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
652.39 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.36 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
817.00 50.51B 3.06B 1.28B 447.35M 19.67

Insmed Inc Stock (INSM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-28 Fortgesetzt Cantor Fitzgerald Overweight
2025-10-20 Eingeleitet Wells Fargo Overweight
2025-08-20 Eingeleitet William Blair Outperform
2025-08-13 Herabstufung Morgan Stanley Overweight → Equal-Weight
2025-05-13 Eingeleitet Jefferies Buy
2025-02-25 Eingeleitet RBC Capital Mkts Outperform
2024-04-23 Eingeleitet Truist Buy
2024-02-15 Eingeleitet Wolfe Research Outperform
2023-12-08 Eingeleitet Wells Fargo Overweight
2023-11-20 Fortgesetzt JP Morgan Overweight
2023-07-26 Eingeleitet Guggenheim Buy
2022-12-09 Eingeleitet Mizuho Buy
2022-12-07 Eingeleitet Barclays Overweight
2022-11-18 Eingeleitet BofA Securities Buy
2022-04-27 Eingeleitet Goldman Buy
2021-12-06 Eingeleitet JP Morgan Overweight
2021-10-19 Fortgesetzt Monness Crespi & Hardt Buy
2021-10-19 Fortgesetzt Morgan Stanley Overweight
2021-10-08 Eingeleitet Cantor Fitzgerald Overweight
2021-04-26 Fortgesetzt Credit Suisse Outperform
2020-12-17 Eingeleitet Berenberg Buy
2020-10-12 Fortgesetzt Stifel Buy
2019-09-03 Eingeleitet Goldman Buy
2019-04-09 Bestätigt H.C. Wainwright Buy
2019-02-15 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 Hochstufung Goldman Neutral → Buy
2019-01-02 Eingeleitet Canaccord Genuity Buy
2018-08-06 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 Eingeleitet Goldman Neutral
2018-04-23 Hochstufung Credit Suisse Neutral → Outperform
2018-03-21 Eingeleitet Morgan Stanley Overweight
2018-01-18 Eingeleitet Credit Suisse Neutral
2017-09-05 Bestätigt Evercore ISI Outperform
2017-08-17 Eingeleitet Evercore ISI Outperform
2017-07-11 Eingeleitet Robert W. Baird Outperform
2016-03-15 Eingeleitet Stifel Buy
2015-11-09 Herabstufung UBS Buy → Neutral
2015-10-06 Bestätigt H.C. Wainwright Buy
2015-06-09 Eingeleitet Citigroup Neutral
2014-03-26 Bestätigt HC Wainwright Buy
Alle ansehen

Insmed Inc Aktie (INSM) Neueste Nachrichten

pulisher
09:13 AM

RBC Raises Price Target on Insmed to $215 From $139, Keeps Outperform Rating - MarketScreener

09:13 AM
pulisher
08:07 AM

Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake - Zacks Investment Research

08:07 AM
pulisher
06:12 AM

Insmed Reaches Analyst Target Price - Nasdaq

06:12 AM
pulisher
05:14 AM

What machine learning models say about Insmed IncorporatedJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com

05:14 AM
pulisher
04:29 AM

Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews

04:29 AM
pulisher
04:28 AM

Why Insmed Incorporated is moving today2025 Fundamental Recap & Free Community Consensus Stock Picks - newser.com

04:28 AM
pulisher
03:58 AM

Insmed Q3 2025 Earnings Call Transcript - MarketBeat

03:58 AM
pulisher
03:29 AM

Insmed earnings missed by $0.41, revenue topped estimates - Investing.com Canada

03:29 AM
pulisher
02:04 AM

Will Insmed Incorporated (IM8N) stock see valuation expansionEarnings Growth Report & Free Fast Gain Swing Trade Alerts - newser.com

02:04 AM
pulisher
12:26 PM

A Look at Insmed (INSM) Valuation Following EU Brensocatib Milestone and ARIKAYCE Revenue Upgrade - Yahoo Finance

12:26 PM
pulisher
12:24 PM

Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus

12:24 PM
pulisher
Oct 30, 2025

Insmed stock price target raised to $223 by TD Cowen on strong Brinsupri launch - Investing.com Nigeria

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed Incorporated (INSM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Oct 30, 2025
pulisher
Oct 30, 2025

INSM: On the Rise Again or Just a Bubble? - StocksToTrade

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed Inc (INSM) Q3 2025 Earnings Call Highlights: Strong Launch for Brin Suri and Robust ... - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed stock hits 52-week high at 170.3 USD By Investing.com - Investing.com South Africa

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed Incorporated Raises Global ARIKAYCE Revenue Guidance for the Full Year 2025 - MarketScreener

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed Reports Strong Sales Growth And Raises Guidance For 2025 - Finimize

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed Q3 2025 slides reveal strong BRINSUPRI debut, ARIKAYCE growth accelerates - Investing.com

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed’s Promising Future: Are Gains Imminent? - StocksToTrade

Oct 30, 2025
pulisher
Oct 30, 2025

Is Insmed Incorporated (IM8N) stock among top earnings playsTrade Risk Assessment & Growth Oriented Trading Recommendations - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How Insmed Incorporated stock reacts to Fed rate cutsEarnings Recap Report & Technical Confirmation Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed’s Strong Financial Performance and Promising Product Launches Reinforce Buy Rating - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

Earnings call transcript: Insmed Q3 2025 sees revenue beat, stock surges - Investing.com

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed: Q3 Earnings Snapshot - CTPost

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed (INSM) 2025 Revenue Projections Reach $473.05 Million - GuruFocus

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed (INSM) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

INSM Surpasses Q3 Revenue Expectations Amid New Product Launch - GuruFocus

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed Q3 Loss Widens, Revenue Rises; Shares up - MarketScreener

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed Inc (INSM) Q3 2025 Earnings: EPS of -$1.25 Beats Estimates, Revenue Surges to $142.4 Million - GuruFocus

Oct 30, 2025
pulisher
Oct 30, 2025

Earnings Flash (INSM) Insmed Posts Q3 Loss $1.75 a Share, vs. FactSet Est of $1.33 Loss - MarketScreener

Oct 30, 2025
pulisher
Oct 30, 2025

Historical volatility pattern of Insmed Incorporated visualizedWeekly Market Outlook & Safe Entry Trade Signal Reports - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Oct 30, 2025
pulisher
Oct 30, 2025

Can Insmed Incorporated stock deliver surprise earnings beatJuly 2025 Volume & Fast Gaining Stock Reports - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Insmed Incorporated stock volume spike explainedRecession Risk & Long-Term Safe Investment Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Gear Up for Insmed (INSM) Q3 Earnings: Wall Street Estimates for Key Metrics - sharewise.com

Oct 30, 2025
pulisher
Oct 30, 2025

What indicators show strength in Insmed IncorporatedBuy Signal & High Accuracy Buy Signal Tips - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Is a relief rally coming for Insmed Incorporated holdersTrade Analysis Summary & Safe Swing Trade Setups - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Will Insmed Incorporated stock outperform Dow Jones indexEarnings Risk Summary & Reliable Price Breakout Signals - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Can Insmed Incorporated stock hit analyst price targetsJuly 2025 Decliners & Intraday High Probability Setup Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Will Insmed Incorporated stock outperform value stocks2025 Support & Resistance & Verified Technical Trade Signals - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

What dividend safety score for Insmed Incorporated stockSwing Trade & Technical Pattern Based Buy Signals - newser.com

Oct 28, 2025

Finanzdaten der Insmed Inc-Aktie (INSM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Insmed Inc-Aktie (INSM) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Schaeffer Orlov S Nicole
Chief People Strategy Officer
Sep 12 '25
Sale
145.45
76,520
11,129,927
36,461
SHAROKY MELVIN MD
Director
Sep 12 '25
Sale
145.39
10,000
1,453,900
262,675
biotechnology ONC
$309.19
price up icon 0.62%
$817.00
price down icon 0.51%
$104.20
price down icon 0.46%
$444.30
price down icon 1.70%
$28.45
price down icon 0.83%
Kapitalisierung:     |  Volumen (24h):